Registration

U.S. GOVERNMENT RELATIONS INTL. for LAKEWOOD-AMEDEX, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Informing members of Congress and staff on the development of the first new class of antimicrobials discovered in the last 3 decades which are being developed to overcome the problem of antibiotic resistant bacteria.

LobbyistCovered position, as disclosed
JEFFREY L TAYLOR New —

Homeland Security HOM

Informing members of Congress and staff on the development of the first new class of antimicrobials discovered in the last 3 decades which are being developed to overcome the problem of antibiotic resistant bacteria.

LobbyistCovered position, as disclosed
JEFFREY L TAYLOR New —

Pharmacy PHA

Informing members of Congress and staff on the development of the first new class of antimicrobials discovered in the last 3 decades which are being developed to overcome the problem of antibiotic resistant bacteria.

LobbyistCovered position, as disclosed
JEFFREY L TAYLOR New —

Health Issues HCR

Informing members of Congress and staff on the development of the first new class of antimicrobials discovered in the last 3 decades which are being developed to overcome the problem of antibiotic resistant bacteria.

LobbyistCovered position, as disclosed
JEFFREY L TAYLOR New —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.